Overview
Vexienne is a science-based, premium brand platform launched by Swedish biotech Coegin Pharma AB in April 2026 as an own-brand distribution model for its proprietary Follicopeptide peptide portfolio, targeting hair thinning.
History
Coegin Pharma merged with Swedish biotech Follicum, source of the Follicopeptide technology (formerly FOL-005)↗
Follicopeptide received INCI approval (ingredient name sh-Oligopeptide-128 SP), May 2024↗
VEXIENNE brand launched as Coegin Pharma's own-brand distribution model for the Follicopeptide portfolio (April 2026)↗
Distribution agreement with LYKO for first VEXIENNE product (Hair Active X); commercial launch expected July 2026↗
Signature products
Ingredients & philosophy
Vexienne positions itself as a science-based, premium hair-care brand built on Coegin Pharma's patented Follicopeptide technology, framed around the idea that hair thinning can be addressed rather than accepted, and presented as an ongoing routine rather than a quick fix.
Ownership & group
Coegin Pharma merged with / acquired Follicum AB (Sweden), acquiring the osteopontin-peptide hair-growth technology later branded Follicopeptide↗
Sources
T1 primary · T2 secondary · T3 note- [1]T1vexienne.comhomepage
- [2]T1vexienne.com/hair-active-xingredients
- [3]T1coeginpharma.com/about-us/about
- [4]T2coeginpharma.com/our-innovations/follicopeptide-hair-density/science
- [5]T1news.bequoted.com/newsroom/coegin-pharma/pressreleases/coegin-pharma-enters-distribution-agreement-with-lyko-for-la-41005/press
- [6]T1inderes.dk/en/releases/coegin-pharma-expands-commercial-strategy-with-own-brand-distribution-model-launches-vexiennerpress
- [7]T3lyko.com/en/vexienne/vexianne-hair-active-x-15-mlexternal_other
- [8]T4hairlosscure2020.com/follicum-is-back-via-coegin-pharma/external_other